Nichole Tucker


Risk-group analysis offers clues to optimizing frontline I/O combos in metastatic kidney cancer

July 26, 2021

Results from a pooled analysis of frontline treatment in metastatic renal cell carcinoma provided early evidence of a differential overall survival benefit between patients with favorable-risk disease compared to patients with intermediate/poor-risk disease.